Close Menu

The Scan

In Cell this week: systems biology analysis of inflammatory syndrome seen in children with COVID-19, single-cell RNA-sequencing strategies, and more.

The Wall Street Journal reports vaccine makers promise to not seek regulatory approval until there is evidence their SARS-CoV-2 vaccines are safe and effective.

Quick Spread

New findings suggest a rapid spread of lactase persistence in Europe, according to Science.

Russian researchers report in the Lancet that their SARS-CoV-2 vaccine leads to an immune response, according to Reuters.

In PNAS this week: possible treatment targets in KRAS-mutated lung cancer, transcriptional analysis of mouse models lacking a p53 inhibitor, and more.

Criteria Not Yet Met

An international committee finds genome editing is not yet ready to be used on human embryos.

The Washington Post discusses how graduate students in the US are affected by the SARS-CoV-2 pandemic and the reopening of universities. 

A German train driver found what turned out to be rodent DNA left on a train, the Associated Press reports.

In Science this week: crystal structures of single-stranded RNA bacteriophages found through metagenomic studies, more.

Memo to Get Ready

CNBC reports the US Centers for Disease Control and Prevention has told states to prepare to distribute a SARS-CoV-2 vaccine by November, though it's unclear if one will be ready then.

According to CNN, 80 Nobel Prize laureates have endorsed Joe Biden for president, citing his "willingness to listen to experts" and "deep appreciation for using science to find solutions." 

To Other Programs

The New York Times reports the US plans to redirect funds it owes in dues to the World Health Organization to other health-related programs at the United Nations.

In Nature this week: holistic allele-specific tumor copy number heterogeneity (HATCHet) approach to infer allele- and clone-specific copy-number aberrations and whole-genome duplications, and more.

Not the US

The US has declined to join a global SARS-CoV-2 vaccine effort, the Washington Post reports.

The Chronicle of Higher Education reports on universities using sewage testing to keep an eye on any uptick in the coronavirus on campus.

If It's Really Good

Late-stage vaccine trials could be stopped early if the data coming out of them is overwhelmingly positive, the Los Angeles Times reports.

In Nucleic Acids Research this week: computational tool to uncover microbial traits from microbiome data, database of patient-derived xenograft from pediatric cancers, and more.

According to Reuters, AstraZeneca has begun enrolling participants into a late-stage study of its candidate SARS-CoV-2 vaccine.

Low Uptake

BBC News reports a free COVID-19 testing program in Hong Kong has had low turnout in part due to DNA surveillance concerns.

Picks Up Too Much

The New York Times reports that some SARS-CoV-2 diagnostic tests might be too sensitive.

In PNAS this week: genetic diversity of SARS-CoV-2 indicates neutral evolution, portable RT-LAMP method to detect SARS-CoV-2, and more.

According to the New York Times, the US is launching a new program to monitor emerging diseases.

China increased the amount it spent on research and development by more than 10 percent in 2019, ScienceInsider says.

Researchers in the UK are building a database of dog DNA to uncover inherited disease among dog breeds with low numbers, Wired UK reports.

In PLOS this week: computational tool to uncover selection within populations, sequencing-based analysis of canine lymphoma, and more.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.